Tag: CBT > Cannabis DEA

Cannabis Rescheduling

3 States Challenge Trump DOJ’s Schedule III Cannabis Rule

Nebraska, Indiana and Louisiana filed a petition for review in federal court, arguing that immediately rescheduling medical cannabis violates administrative procedures.

May 27, 2026

Hemp-Derived Cannabinoids

White House’s ‘New Legal Authority’ for Hemp THC Products Leads CBT’s Top Stories in May

The Trump administration’s drug control strategy indicated enforcement of intoxicating hemp products that have largely gone unregulated.

May 27, 2026

Cannabis Rescheduling

Cresco Labs Marks Historic Step Forward With Medical Cannabis Facility DEA Registrations

The registrations are for the company’s dispensary, cultivation and processing operations.

May 27, 2026

Cannabis Rescheduling

DEA’s Schedule III Cannabis Registration ‘Coming Soon’ For Cultivators, Manufacturers, Distributors, Labs

The application for non-dispensary businesses to handle Schedule III medical cannabis will be available in the coming weeks.

May 11, 2026

Cannabis Rescheduling

LEEF Brands Files Applications for DEA Registration, Positioning for Interstate and Global Export Opportunities

The California cannabis company expects interstate and global exports to provide an opportunity to sell into other markets at meaningfully higher prices.

May 8, 2026

Cannabis Rescheduling

Medical Cannabis Businesses ‘Need to Register’ With DEA to Be Schedule III Compliant

The DOJ’s rescheduling order does ‘not immediately’ bring state-licensed operators into compliance with federal law, congressional researchers say.

May 4, 2026

Cannabis Rescheduling

DEA Schedule III Registration Asks Cannabis Businesses to Admit to Drug Trafficking

State-licensed medical cannabis businesses have 60 days to apply for the federal registration to receive an expedited review; providing false info is punishable by jail.

April 30, 2026

Cannabis Rescheduling

Trulieve Files Applications for DEA Registration of State-Licensed Medical Marijuana Businesses

The company has 200-plus medical cannabis dispensaries it plans to register under the DEA’s expedited process for Schedule III.

April 29, 2026

The Last Word

Trulieve CEO ‘Not Concerned’ by DEA’s Middleman Role in Schedule III Order

Kim Rivers dives into the feds’ impending access to her company’s facilities and other treaty obligations, as well as 280E taxes, product development and scientific research.

April 24, 2026

Cannabis Rescheduling

Cannabis Industry Stakeholders React to Trump DOJ’s Rescheduling Order, New Hearing

The Department of Justice’s two-phase rescheduling plan includes an immediate order and a new, expedited hearing process.

April 23, 2026

Cannabis Rescheduling

Trump DOJ Moves to Reschedule Cannabis, Orders New Expedited Hearing

U.S. Acting Attorney General Todd Blanche signed an order to reschedule cannabis and set deadlines for a new DEA hearing.

April 23, 2026

Cannabis Rescheduling

US Congressman Presses DOJ, DEA Heads on Cannabis Rescheduling Timeline

Democratic Rep. Steve Cohen sent a letter to Attorney General Pam Bondi and DEA Administrator Terry Cole asking for a status update.

March 27, 2026